Treatment outcomes of neoadjuvant immunotherapy in patients with locally advanced melanoma

[HTML] nih.gov

Neoadjuvant pembrolizumab and high-dose IFNα-2b in resectable regionally advanced melanoma

YG Najjar, D McCurry, H Lin, Y Lin, Y Zang… - Clinical Cancer …, 2021 - AACR
Purpose: Neoadjuvant immunotherapy may improve the clinical outcome of regionally
advanced operable melanoma and allows for rapid clinical and pathologic assessment of …
被引用次数：24 相关文章 所有 7 个版本

Neoadjuvant versus adjuvant immune checkpoint blockade in the treatment of clinical stage III melanoma

Y Song, RJ Straker, X Xu, DE Elder, PA Gimotty… - Annals of Surgical …, 2020 - Springer
Background Immune checkpoint blockade (ICB) has transformed melanoma treatment, but
optimal sequencing of ICB and surgery for clinically evident nodal metastasis remains …
被引用次数：14 相关文章 所有 4 个版本
[PDF] mdpi.com

“To anticipate”: neoadjuvant therapy in melanoma with a focus on predictive biomarkers

M Garutti, S Buriolla, E Bertoli, MG Vitale, E Rossi… - Cancers, 2020 - mdpi.com
Despite surgical resection and adjuvant therapies, stage III melanomas still have a
substantial risk of relapse. Neoadjuvant therapy is an emerging strategy that might offer …
被引用次数：5 相关文章 所有 12 个版本

[引用][C] Cost effectiveness of treatment strategies for skin cancer in the Irish Healthcare Setting

C Gorry - 2020 - Doctoral dissertation, Trinity College …
被引用次数：1 相关文章